MDI Health Market Research Report
Company Overview
- Name: MDI Health
- Mission: MDI Health envisions a world in which complex medication regimens are no longer a major threat to human health. They aim to empower clinical teams to improve care quality, scale, quantify clinical and financial impacts, and reduce total care costs through their medication management technology.
- Founded: 2019
- Founders:
- Avishai Ben Tovim, CEO & Co-Founder
- Dr. Dorit Dil Nahlieli, Co-Founder & Chief Scientist
- Yuval Kalev, Co-Founder & CTO
- Headquarters: Los Angeles, US
- Number of Employees: 11-50 employees
- Industry: Hospitals and Health Care
- Revenue: No information is available
- Known For: MDI Health is known for its advanced AI-driven medication management platform that significantly reduces Rx and medical costs by optimizing medication treatment, managing high-risk populations, and preventing costly medical complications.
Products
- Personalized AI Medication Management Platform
- Description: MDI's platform is designed to optimize medication management by providing comprehensive and scalable solutions.
- Key Features:
- Automated and Hyper-personalized: Offers automated solutions that deliver hyper-personalized recommendations and analyses of medication-related risks.
- Preventative: Aiming to prevent drug-related adverse medical events through rigorous data collection and analysis.
- SOC 2 Type II Certified: Ensures data integrity, security, and compliance.
- Comprehensive Risk Analysis: Quickly generates risk-mapping for patient evaluation and management.
- Continuous Monitoring: Monitors medication treatment and provides alerts for adverse drug reactions.
Recent Developments
- Recent Products Launched: MDI Health launched their AI medication management platform, which is designed to innovate, personalize, and scale medication treatment.
- Innovative Features: Their AI technology generates evidence-based recommendations and synthesizes medication-related risks using thousands of pharmacological and medical parameters.
- Partnerships:
- Participated in programs like Digital Health CT Cohort, Hadassah Hospital and IBM's Medtech Accelerator.
- Received funding, including a $6 million seed round and a $20 million Series A, with notable investors such as Intel Capital.
- Awards and Recognition:
- Received the "Best New Technology Solution for Medication Management" award at the MedTech Breakthrough Awards.
Key People in the Company
- Avishai Ben Tovim: CEO & Co-Founder
- Dr. Dorit Dil Nahlieli: Co-Founder & Chief Scientist
- Yuval Kalev: Co-Founder & CTO
- Asaf Broide: VP of Product
- Brad Margolis: COO
- Dr. Veronica Michalowitz: Clinical Services & Research
- Ariel Efergan: VP of Growth
- Adi Simon: Head of Product Design
Advisory Board
- Dr. Geeta Nayyar, MD, MBA: CMO Salesforce (Former)
- Richard L. Boals: Former CEO, Blue Cross Blue Shield Arizona
- Richard J Montwill: Executive Vice President, Optum
- Dr. Richard Popiel, MD, MBA: CMO Cambia Health (Former), Senior Advisor McKinsey
- Jacqueline Kosecoff, PhD: Health Plan Executive, Board member: Alignment Healthcare, GoodRx, Virgin Pulse
- Ruth Raskas: VP Anthem | AI & VBC strategy
- Dr. Eitan Hyam: Former Director General, Israeli Ministry of Health
- Dr. Sigal Tikva Shefran: Head of Research & Innovation Center in Nursing, Hadassah Hospital
- Professor Arie Ben Yehuda: Chairman of the Department of Medicine, Hadassah
Note
- The company continues to innovate and expand its influence in the health care industry, especially in medication management, through various strategic partnerships and investments.
This report provides a concise and comprehensive view of MDI Health based on available data. Further exploration is necessary for information not present, such as specific financial data and additional developments.
